References
- Draper AJ, Madan A, Parkinson A. (1997). Inhibition of coumarin 7-hydroxylase activity in human liver microsomes. Arch Biochem Biophys 341:47–61.
- Linder CD, Renaud NA, Hutzler JM. (2009). Is 1-aminobenzotriazole an appropriate in vitro tool as a nonspecific cytochrome P450 inactivator? Drug Metab Dispos 37:10–13.
- Nirogi R, Palacharla RC, Uthukam V, et al. (2015). Chemical inhibitors of CYP450 enzymes in liver microsomes: combining selectivity and unbound fractions to guide selection of appropriate concentration in phenotyping assays. Xenobiotica 45:95–106.
- Nirogi R, Palacharla RC, Mohammed AR, et al. (2015). Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction. Chem Biol Interact 230:9–20.
- Palacharla RC, Nirogi R, Uthukam V, et al. (2017). Quantitative in vitro phenotyping and prediction of drug interaction potential of CYP2B6 substrates as victims. Xenobiotica 28:1–13.
- Zhang W, Kilicarslan T, Tyndale RF, Sellers EM. (2001). Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro. Drug Metab Dispos 29:897–902.
- Zhu HJ, Wang X, Gawronski BE, et al. (2013). Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation. J Pharmacol Exp Ther 344:665–72.